CIPLA
Cipla Gets Final Approval for Generic Version of GlaxoSmithKline's IMITREX
Cost Effective Process Technology of Favipiravir Developed by CSIR Used by M/s Cipla Ltd.
Cipla Signed Licensing Pact with Gilead to Manufacture & Distribute Remdesivir
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
/smstreet/media/post_banners/MAb8XzCQW4JFsilXspsR.jpg)
/smstreet/media/post_banners/tUELilopmmMhH9WEmacY.jpeg)
/smstreet/media/post_banners/x04IXwySYFOSXkLOnzoV.jpg)
/smstreet/media/post_banners/RsBrNSckDwizvYFUlXTP.jpeg)
/smstreet/media/post_banners/HdiSiGvCzxHveMOVaWDU.jpg)
/smstreet/media/post_banners/mI3vFKtfJ7uFMwLGBLsN.jpg)
